Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer (Q38931798)

7 September 2017

title

Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer (English)

1 reference

7 September 2017

Jun Dai

1

1 reference

7 September 2017

Jin-yu Wang

2

1 reference

7 September 2017

Li-li Yang

3

1 reference

7 September 2017

Ying Xiao

4

1 reference

7 September 2017

Zhi-ling Qu

5

1 reference

7 September 2017

Sheng-hui Qin

6

1 reference

7 September 2017

Qiu-rong Ruan

7

1 reference

7 September 2017

publication date

6 December 2014

1 reference

Journal of Huazhong University of Science and Technology. Medical Sciences

7 September 2017

published in

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

896-901

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

The Foxc2 transcription factor regulates tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Foxc2 induces expression of MyoD and differentiation of the mouse myoblast cell line C2C12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Impact of basal-like breast carcinoma determination for a more specific therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Evolutionary genomics of the Fox genes: origin of gene families and the ancestry of gene clusters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Epithelial mesenchymal transition traits in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11596-014-1370-5

The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?

21 January 2018

1 reference

12 December 2020

Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype

1 reference

12 December 2020

Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non–Small-Cell Lung Cancer After Curative Resection

1 reference

12 December 2020

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

1 reference

12 December 2020

Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer.

1 reference

12 December 2020

10.1007/S11596-014-1370-5

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1034313018

0 references

1 reference